{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:12Z","timestamp":1785796872576,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78787-4","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T10:02:07Z","timestamp":1735034527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of cardiovascular disease on cancer: observational and mendelian randomization analyses"],"prefix":"10.1038","volume":"14","author":[{"given":"Tongtong","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3231-7627","authenticated-orcid":false,"given":"Chengyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"78787_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)00371-3","volume":"399","author":"L The","year":"2022","unstructured":"The, L. Our commitment to help accelerate progress against cancer. Lancet (London England). 399, 769 (2022).","journal-title":"Lancet (London England)"},{"key":"78787_CR2","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S1470-2045(23)00636-8","volume":"25","author":"M Schlander","year":"2024","unstructured":"Schlander, M. et al. The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions. Lancet Oncol. 25, e152\u2013e163 (2024).","journal-title":"Lancet Oncol."},{"key":"78787_CR3","doi-asserted-by":"crossref","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. (2024).","DOI":"10.3322\/caac.21834"},{"key":"78787_CR4","first-page":"g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ (Clinical Res. ed.). 350, g7607 (2015).","journal-title":"BMJ (Clinical Res. ed.)"},{"key":"78787_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","volume":"394","author":"H Strongman","year":"2019","unstructured":"Strongman, H. et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet (London England). 394, 1041\u20131054 (2019).","journal-title":"Lancet (London England)"},{"key":"78787_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jtho.2023.09.004","volume":"19","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Bidirectional association between cardiovascular disease and lung cancer in a prospective cohort study. J. Thorac. Oncol. 19, 80\u201393 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"78787_CR7","doi-asserted-by":"crossref","unstructured":"Guan, T. et al. Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers. J. Adv. Res. (2024).","DOI":"10.1016\/j.jare.2024.03.017"},{"key":"78787_CR8","doi-asserted-by":"crossref","unstructured":"Saad, E. E., Michel, R. & Borahay, M. A. Cholesterol and immune microenvironment: path towards tumorigenesis. Curr. Nutr. Rep. (2024).","DOI":"10.1007\/s13668-024-00542-y"},{"key":"78787_CR9","doi-asserted-by":"crossref","unstructured":"Wilcox, N. S. et al. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat. Rev. Cardiol. (2024).","DOI":"10.1038\/s41569-024-01017-x"},{"key":"78787_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","volume":"3","author":"ES Lau","year":"2021","unstructured":"Lau, E. S. et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 3, 48\u201358 (2021).","journal-title":"JACC CardioOncol."},{"key":"78787_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer, R. A., Meijers, W. C., van der Meer, P. & van Veldhuisen, D. J. Cancer and heart disease: associations and relations. Eur. J. Heart Fail. 21, 1515\u20131525 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"78787_CR12","doi-asserted-by":"crossref","unstructured":"Vo, J. B. et al. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors. J. Natl. Cancer Inst. (2024).","DOI":"10.1093\/jnci\/djae107"},{"key":"78787_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A. & Timpson, N., Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163 (2008).","journal-title":"Stat. Med."},{"key":"78787_CR14","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/ndt\/gfq098","volume":"25","author":"M Verduijn","year":"2010","unstructured":"Verduijn, M., Siegerink, B., Jager, K. J., Zoccali, C. & Dekker, F. W. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol. Dial. Transplant. 25, 1394\u20131398 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"78787_CR15","unstructured":"Statistics, N. C. F. H. About the National Health and Nutrition Examination Survey. https:\/\/www.cdc.gov\/nchs\/nhanes\/about_nhanes.htm (2023)."},{"key":"78787_CR16","unstructured":"Statistics, N. C. f. H. NCHS Ethics Review Board (ERB) Approval. https:\/\/www.cdc.gov\/nchs\/nhanes\/irba98.htm (2022)."},{"key":"78787_CR17","unstructured":"Statistics, N. C. f. H. NHANES Medical Conditions (MCQ_F). https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Default.aspx (2011)."},{"key":"78787_CR18","doi-asserted-by":"publisher","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","volume":"11","author":"W Yu","year":"2020","unstructured":"Yu, W. & Cheng, J. D. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front. Pharmacol. 11, 582680 (2020).","journal-title":"Front. Pharmacol."},{"key":"78787_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/clinchem\/hvad202","volume":"70","author":"SM Schwartz","year":"2024","unstructured":"Schwartz, S. M. Epidemiology of cancer. Clin. Chem. 70, 140\u2013149 (2024).","journal-title":"Clin. Chem."},{"key":"78787_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12012-024-09845-6","volume":"24","author":"R Shen","year":"2024","unstructured":"Shen, R. & Zou, T. Association between cancer and cardiovascular toxicity: a nationwide cross-sectional study on NHANES 1999\u20132018. Cardiovasc. Toxicol. 24, 351\u2013364 (2024).","journal-title":"Cardiovasc. Toxicol."},{"key":"78787_CR21","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.cpcardiol.2022.101540","volume":"48","author":"F Petermann-Rocha","year":"2023","unstructured":"Petermann-Rocha, F. et al. An opportunity for prevention: associations between the life\u2019s essential 8 score and cardiovascular incidence using prospective data from UK Biobank. Curr. Probl. Cardiol. 48, 101540 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"78787_CR22","doi-asserted-by":"publisher","first-page":"107853","DOI":"10.1016\/j.ypmed.2024.107853","volume":"179","author":"C Fan","year":"2024","unstructured":"Fan, C., Zhu, W., He, Y. & Da, M. The association between life\u2019s essential 8 and all-cause, cancer and non-cancer mortality in US cancer survivors: a retrospective cohort study of NHANES. Prev. Med. 179, 107853 (2024).","journal-title":"Prev. Med."},{"key":"78787_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13058-024-01877-8","volume":"26","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Song, Y., Li, X. & Guo, A. Association of Life\u2019s essential 8 cardiovascular health with breast cancer incidence and mortality according to genetic susceptibility of breast cancer: a prospective cohort study. Breast Cancer Res. BCR. 26, 121 (2024).","journal-title":"Breast Cancer Res. BCR"},{"key":"78787_CR24","doi-asserted-by":"crossref","unstructured":"Yan, S. et al. Serum uric acid increases risk of cancer incidence and mortality: a systematic review and meta-analysis. Mediat. Inflamm. 2015, 764250 (2015).","DOI":"10.1155\/2015\/764250"},{"key":"78787_CR25","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones, D. M. et al. Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of Cardiovascular Health: a presidential advisory from the American Heart Association. Circulation. 146, e18\u2013e43 (2022).","journal-title":"Circulation"},{"key":"78787_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","volume":"158","author":"Z Ruan","year":"2022","unstructured":"Ruan, Z. et al. Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults. JAMA Dermatol. 158, 745\u2013753 (2022).","journal-title":"JAMA Dermatol."},{"key":"78787_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s43587-021-00051-5","volume":"1","author":"HM D\u00f6nerta\u015f","year":"2021","unstructured":"D\u00f6nerta\u015f, H. M., Fabian, D. K., Valenzuela, M. F., Partridge, L. & Thornton, J. M. Common genetic associations between age-related diseases. Nat. Aging. 1, 400\u2013412 (2021).","journal-title":"Nat. Aging"},{"key":"78787_CR28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415\u20131424 (2021).","journal-title":"Nat. Genet."},{"key":"78787_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524\u2013537 (2018).","journal-title":"Nat. Genet."},{"key":"78787_CR30","unstructured":"Bristol, U. O. GWAS summary data\u2014IEU OpenGWAS project. https:\/\/gwas.mrcieu.ac.uk\/ (2024)."},{"key":"78787_CR31","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1038\/s41467-021-21952-4","volume":"12","author":"M Guindo-Mart\u00ednez","year":"2021","unstructured":"Guindo-Mart\u00ednez, M. et al. The impact of non-additive genetic associations on age-related complex diseases. Nat. Commun. 12, 2436 (2021).","journal-title":"Nat. Commun."},{"key":"78787_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ng.3892","volume":"49","author":"JD McKay","year":"2017","unstructured":"McKay, J. D. et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat. Genet. 49, 1126\u20131132 (2017).","journal-title":"Nat. Genet."},{"key":"78787_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"78787_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","volume":"51","author":"JR Huyghe","year":"2019","unstructured":"Huyghe, J. R. et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat. Genet. 51, 76\u201387 (2019).","journal-title":"Nat. Genet."},{"key":"78787_CR35","doi-asserted-by":"publisher","first-page":"131362","DOI":"10.1016\/j.ijcard.2023.131362","volume":"396","author":"D He","year":"2024","unstructured":"He, D. et al. Increased incidence risks of cardiovascular disease among cancer patients: evidence from a population-based cohort study in China. Int. J. Cardiol. 396, 131362 (2024).","journal-title":"Int. J. Cardiol."},{"key":"78787_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jamaoto.2023.1342","volume":"149","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Risk of cardiovascular events among patients with head and neck cancer. JAMA Otolaryngol. Head Neck Surg. 149, 717\u2013725 (2023).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"78787_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","volume":"170","author":"SAM Gernaat","year":"2018","unstructured":"Gernaat, S. A. M. et al. The risk of cardiovascular disease following breast cancer by Framingham risk score. Breast Cancer Res. Treat. 170, 119\u2013127 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"78787_CR38","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889\u20133897 (2019).","journal-title":"Eur. Heart J."},{"key":"78787_CR39","doi-asserted-by":"publisher","first-page":"e2112049","DOI":"10.1001\/jamanetworkopen.2021.12049","volume":"4","author":"D Ramai","year":"2021","unstructured":"Ramai, D. et al. Population-based long-term Cardiac-Specific Mortality among patients with Major gastrointestinal cancers. JAMA Netw. Open. 4, e2112049 (2021).","journal-title":"JAMA Netw. Open."},{"key":"78787_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5694\/mja2.50879","volume":"214","author":"B Koczwara","year":"2021","unstructured":"Koczwara, B. et al. Late mortality in people with cancer: a population-based Australian study. Med. J. Aust. 214, 318\u2013323 (2021).","journal-title":"Med. J. Aust."},{"key":"78787_CR41","doi-asserted-by":"publisher","first-page":"1344515","DOI":"10.3389\/fcvm.2024.1344515","volume":"11","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Wang, Z., Yu, J. & Chen, L. Thyroid cancer and cardiovascular diseases: a mendelian randomization study. Front. Cardiovasc. Med. 11, 1344515 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"78787_CR42","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.7150\/jca.94142","volume":"15","author":"T Sun","year":"2024","unstructured":"Sun, T. et al. Mendelian randomization combined with multi-omics explores the relationship between heart failure and cancer. J. Cancer. 15, 2928\u20132939 (2024).","journal-title":"J. Cancer"},{"key":"78787_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12916-019-1474-7","volume":"18","author":"H Freisling","year":"2020","unstructured":"Freisling, H. et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 18, 5 (2020).","journal-title":"BMC Med."},{"key":"78787_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12916-023-03114-z","volume":"21","author":"E Fontvieille","year":"2023","unstructured":"Fontvieille, E. et al. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21, 418 (2023).","journal-title":"BMC Med."},{"key":"78787_CR45","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene, R. J., Prizment, A. E., Blaes, A. & Konety, S. H. Shared risk factors in cardiovascular disease and cancer. Circulation. 133, 1104\u20131114 (2016).","journal-title":"Circulation"},{"key":"78787_CR46","doi-asserted-by":"publisher","first-page":"100771","DOI":"10.1016\/j.lanepe.2023.100771","volume":"35","author":"R Cordova","year":"2023","unstructured":"Cordova, R. et al. Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Lancet Reg. Health Europe. 35, 100771 (2023).","journal-title":"Lancet Reg. Health Europe"},{"key":"78787_CR47","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh, E. T. & Bickford, C. L. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J. Am. Coll. Cardiol. 53, 2231\u20132247 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"78787_CR48","doi-asserted-by":"crossref","unstructured":"Acevedo, F. et al. Oncological benefit versus cardiovascular risk in breast cancer patients treated with modern radiotherapy. J. Clin. Med. 11 (2022).","DOI":"10.3390\/jcm11133889"},{"key":"78787_CR49","doi-asserted-by":"publisher","first-page":"102956","DOI":"10.1016\/j.ebiom.2020.102956","volume":"59","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample mendelian randomization study. EBioMedicine. 59, 102956 (2020).","journal-title":"EBioMedicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78787-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T11:03:42Z","timestamp":1735038222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78787-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78787"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78787-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28465"}}